Literature DB >> 18634772

PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.

Jelena Kotur-Stevuljevic1, Slavica Spasic, Zorana Jelic-Ivanovic, Vesna Spasojevic-Kalimanovska, Aleksandra Stefanovic, Ana Vujovic, Lidija Memon, Dimitra Kalimanovska-Ostric.   

Abstract

OBJECTIVES: High-density lipoprotein (HDL) associated paraoxonase 1 (PON1) is an essential component of HDLs' capability to protect low-density lipoproteins (LDL) from oxidative modification and thus to limit the atherosclerotic process. The aim of the current study was to investigate the association between oxidative stress status, indices of inflammation and PON1 status parameters. DESIGN AND METHODS: We determined the relationship between the oxidative stress status, inflammatory markers and PON1 status parameters in 261 middle-aged subjects: 156 coronary heart disease (CHD) patients and 105 CHD-free subjects (as the control group). The PON1 status involved PON1 activity measurements towards two substrates: paraoxon (POase activity) and diazoxon (DZOase activity) and subsequent PON1(Q192R) activity phenotype determination.
RESULTS: A statistically significant greater malondialdehyde (MDA) concentration in the RR phenotype subjects compared to QQ subjects within the CHD group was apparent (P<0.05). Multiple linear regression analysis revealed an independent influence of plasmatic SOD activity (P<0.05) on POase values and MDA (P<0.01) and O(2)(-) (P<0.05) on DZOase values. Involvement of inflammatory markers (fibrinogen and hsCRP) in the regression model did not hinder the influence of SOD and MDA on POase and DZOase activities, respectively.
CONCLUSIONS: Our CHD patients were in a state of oxidative stress, which was most evident in the RR phenotype group. The QQ phenotype group is associated with the lowest oxidative stress status level and also with a better capacity for anti-oxidative protection. Oxidative stress in CHD patients is maintained by systemic low-grade inflammation, which results in PON1 enzymatic activity exhaustion. Therefore, deeper investigation of an effective anti-oxidative and anti-inflammatory therapy should be necessary in order to increase anti-oxidative potency and improve PON1 status of CHD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634772     DOI: 10.1016/j.clinbiochem.2008.06.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

2.  Serum paraoxonase and arylesterase activities in patients with chronic otitis media.

Authors:  Mahfuz Turan; Rıfkı Ucler; Mehmet Aslan; Ferhat Kalkan; Abdullah Taskın; Mehmet Fatih Garca; Hakan Cankaya
Journal:  Redox Rep       Date:  2015-05-13       Impact factor: 4.412

3.  Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament.

Authors:  M Atli
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

4.  Associations of lipoprotein subclasses and oxidative stress status in pulmonary and pulmonary plus extrapulmonary sarcoidosis.

Authors:  Jasmina Ivaniševic; Jelena Vekic; Aleksandra Zeljkovic; Aleksandra Stefanovic; Jelena Kotur-Stevuljevic; Vesna Spasojevic-Kalimanovska; Slavica Spasic; Violeta Vucinic-Mihailovic; Jelica Videnovic-Ivanov; Zorana Jelic-Ivanovic
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

5.  Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.

Authors:  Ramazan Esen; Mehmet Aslan; Mehmet Emin Kucukoglu; Aytekin Cıkman; Umit Yakan; Mahmut Sunnetcioglu; Sahbettin Selek
Journal:  Wien Klin Wochenschr       Date:  2015-02-24       Impact factor: 1.704

6.  The Therapeutic Role of Slit2 in Anti-fibrosis, Anti-inflammation and Anti-oxidative Stress in Rats with Coronary Heart Disease.

Authors:  Ji-Wei Liu; Hai-Tao Liu; Lin Chen
Journal:  Cardiovasc Toxicol       Date:  2021-08-19       Impact factor: 3.231

7.  Paraoxonase-1 Facilitates PRRSV Replication by Interacting with Viral Nonstructural Protein-9 and Inhibiting Type I Interferon Pathway.

Authors:  Lin Zhang; Yu Pan; Yunfei Xu; Wenli Zhang; Wenjie Ma; Yassein M Ibrahim; Gebremeskel Mamu Werid; He Zhang; Changyou Xia; Ping Wei; Hongyan Chen; Yue Wang
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

8.  Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy.

Authors:  Hande Koksal; Sevil Kurban
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

9.  Serum paraoxonase and arylesterase activities and oxidative stress levels in patients with SSRI intoxication.

Authors:  Celal Katı; Sevdegul Karadas; Mehmet Aslan; Hayriye Gonullu; Latif Duran; Halit Demir
Journal:  J Membr Biol       Date:  2013-11-02       Impact factor: 1.843

10.  Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.

Authors:  Chiyan Zhou; Jia Cao; Liang Shang; Chuanfeng Tong; Hanling Hu; Hui Wang; Daping Fan; Hong Yu
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.